Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Male Infertility Treatment Market, 2014 2022 (USD Million)

2.2. Global Male Infertility Treatment Market: Snapshot

Chapter 3. Male Infertility Treatment Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Male Infertility Treatment Market Drivers: Impact Analysis

3.3.2. Obesity

3.3.3. Torpid lifestyle

3.4. Market Restraints


3.4.1. Global Male Infertility Treatment Market Restraints: Impact Analysis

3.4.2. Lack Of Education, discontinuation of treatment

3.5. Opportunities


3.5.1. Covering Untapped Market

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Techniques Segment

3.7.2. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Male Infertility Treatment Market Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Regional Expansion

4.3. Type Portfolio

Chapter 5. Global Male Infertility Treatment Market Techniques Analysis


5.1. Global Male Infertility Treatment Market: Techniques Overview


5.1.1. Global Male Infertility Treatment Market Revenue Share, By Techniques , 2016 And 2022

5.2. DNA Fragmentation


5.2.1. Global DNA Fragmentation Market, 2014 2022 (USD Million)

5.3. Oxidative Stress Analysis


5.3.1. Global Oxidative Stress Analysis Market, 2014 2022 (USD Million)

5.4. Sperm Penetration


5.4.1. Global Sperm Penetration Market, 2014 2022 (USD Million)

5.5. Microscopic Analysis


5.5.1. Global Microscopic Analysis Market, 2014 2022 (USD Million)

5.6. Sperm Agglutination


5.6.1. Global Sperm Agglutination Market, 2014 2022 (USD Million)

5.7. Others


5.7.1. Global Other Male Infertility Treatment Market, 2014 2022 (USD Million)

Chapter 6. Global Male Infertility Treatment Market Regional Segment Analysis


6.1. Global Male Infertility Treatment Market: Regional Overview


6.1.1. Global Male Infertility Treatment Market Revenue Share, By Region, 2016 And 2022

6.2. North America


6.2.1. North America Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 , (USD Million)

6.2.2. U.S.


6.2.2.1. U.S. Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.3. Europe


6.3.1. Europe Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.3.2. Germany


6.3.2.1. Germany Male Infertility Treatment Market Revenue, By Techniques , 2014 2022, (USD Million)

6.3.3. France


6.3.3.1. France Male Infertility Treatment Market Revenue, By Techniques , 2014 2022, (USD Million)

6.3.4. UK


6.3.4.1. UK Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.4. Asia Pacific


6.4.1. Asia Pacific Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.4.2. China


6.4.2.1. China Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.4.3. Japan


6.4.3.1. Japan Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.4.4. India


6.4.4.1. India Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.5. Latin America


6.5.1. Latin America Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.5.2. Brazil


6.5.2.1. Brazil Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

6.6. Middle East And Africa


6.6.1. Middle East And Africa Male Infertility Treatment Market Revenue, By Techniques , 2014 2022 (USD Million)

Chapter 7. Company Profile


7.1. ASKA Pharmaceutical Co. Ltd


7.1.1. Overview

7.1.2. Financials

7.1.3. Product Portfolio

7.1.4. Business Strategy

7.1.5. Recent Developments

7.2. Zydus Cadila Healthcare Limited,


7.2.1. Overview

7.2.2. Financials

7.2.3. Product Portfolio

7.2.4. Business Strategy

7.2.5. Recent Developments

7.3. Access Pharmaceuticals, Inc.


7.3.1. Overview

7.3.2. Financials

7.3.3. Product Portfolio

7.3.4. Business Strategy

7.3.5. Recent Developments

7.4. Intas Pharmaceuticals Ltd.


7.4.1. Overview

7.4.2. Financials

7.4.3. Product Portfolio

7.4.4. Business Strategy

7.4.5. Recent Developments

7.5. Pantarhei Bioscience B


7.5.1. Overview

7.5.2. Financials

7.5.3. Product Portfolio

7.5.4. Business Strategy

7.5.5. Recent Developments

7.6. Cordex Pharma, Inc.


7.6.1. Overview

7.6.2. Financials

7.6.3. Product Portfolio

7.6.4. Business Strategy

7.6.5. Recent Developments

7.7. Merck Serono


7.7.1. Overview

7.7.2. Financials

7.7.3. Product Portfolio

7.7.4. Business Strategy

7.7.5. Recent Developments

7.8. Halotech DNA SL


7.8.1. Overview

7.8.2. Financials

7.8.3. Product Portfolio

7.8.4. Business Strategy

7.8.5. Recent Developments

7.9. SCSA diagnostics


7.9.1. Overview

7.9.2. Financials

7.9.3. Product Portfolio

7.9.4. Business Strategy

7.9.5. Recent Developments

7.10. Andrology Solutions


7.10.1. Overview

7.10.2. Financials

7.10.3. Product Portfolio

7.10.4. Business Strategy

7.10.5. Recent Developments